Although the amplification of SPAG9/JLP was observed only in 3 % of the cases analyzed, the increased expression correlates with the decreased disease-free survival of ovarian cancer patients (Supplementary Material S2). The gene discussed is SPAG9; the disease is ovarian carcinoma.